Depomed Yanks Diabetes Drug Glumetza

Law360, New York (June 17, 2010, 1:31 PM EDT) -- Drugmaker Depomed Inc. on Thursday recalled 52 lots of the diabetes medication Glumetza after finding trace amounts of 2,4,6-tribromoanisole, a chemical that is also linked to a recently expanded product recall by a Johnson & Johnson unit.

Menlo Park, Calif.-based Depomed said in a U.S. Securities and Exchange Commission filing that the recall was prompted by a complaint that a package of the 500 mg tablets had a smell and taste that is consistent with TBA, which is often used on wood pallets as a fungicide....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.